Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lindberg

Showing results (201-210 of 233) with videos related to

Pageof 24
Sort By:
Journal of Medicinal Chemistry|February 1, 1985
Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonistsH Wikström, B Andersson, D Sanchez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 19, 2016
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML developmentMaria Meira, Claudia Sievers, Francine Hoffmann, et al.
Journal of Neurology|March 6, 2007
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSFJens Kuhle, Raija L P Lindberg, Axel Regeniter, et al.
Neurology|October 15, 2008
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosisM Mehling, V Brinkmann, J Antel, et al.
Journal of Neuropathology and Experimental Neurology|April 24, 2008
Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteinsHideyuki Ishihara, Hisashi Kubota, Raija L P Lindberg, et al.
Acta Pharmaceutica Suecica|January 1, 1985
5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effectsU Hacksell, L E Arvidsson, A M Johansson, et al.
Journal of Medicinal Chemistry|January 1, 1988
N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonistsL E Arvidsson, A M Johansson, U Hacksell, et al.
Annals of Neurology|March 10, 2011
Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patientsMatthias Mehling, Patricia Hilbert, Stefanie Fritz, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1981
Effects of a new type of 5-HT receptor agonist on male rat sexual behaviorS Ahlenius, K Larsson, L Svensson, et al.
Biotechnology and Bioengineering|May 28, 2011
Evaluation of protein engineering and process optimization approaches to enhance antibody drug manufacturabilityGreg P Conley, Malini Viswanathan, Ying Hou, et al.
Pageof 24

Showing results (201-210 of 233) with videos related to

Sort By:
Pageof 24
Journal of Medicinal Chemistry|February 1, 1985
Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonistsH Wikström, B Andersson, D Sanchez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 19, 2016
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML developmentMaria Meira, Claudia Sievers, Francine Hoffmann, et al.
Journal of Neurology|March 6, 2007
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSFJens Kuhle, Raija L P Lindberg, Axel Regeniter, et al.
Neurology|October 15, 2008
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosisM Mehling, V Brinkmann, J Antel, et al.
Journal of Neuropathology and Experimental Neurology|April 24, 2008
Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteinsHideyuki Ishihara, Hisashi Kubota, Raija L P Lindberg, et al.
Acta Pharmaceutica Suecica|January 1, 1985
5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effectsU Hacksell, L E Arvidsson, A M Johansson, et al.
Journal of Medicinal Chemistry|January 1, 1988
N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonistsL E Arvidsson, A M Johansson, U Hacksell, et al.
Annals of Neurology|March 10, 2011
Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patientsMatthias Mehling, Patricia Hilbert, Stefanie Fritz, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1981
Effects of a new type of 5-HT receptor agonist on male rat sexual behaviorS Ahlenius, K Larsson, L Svensson, et al.
Biotechnology and Bioengineering|May 28, 2011
Evaluation of protein engineering and process optimization approaches to enhance antibody drug manufacturabilityGreg P Conley, Malini Viswanathan, Ying Hou, et al.
Pageof 24